Based on the limited information provided; the grafts remain implanted.According to records review, serial id#: (b)(4) processed from the lot met all acceptance / inspection criteria prior to distribution.The graft was manufactured to the specification detailed in sp (b)(4)"04", annex 1-3 "06", annex "02".This case is considered not serious by the reporting investigator and by tutogen as no medical intervention had to be performed due to the event.Seroma is frequently reported after surgery, especially, when lymphatic vessels have been cut, for example during breast reconstruction with lymph node resection due to breast cancer.Additionally, seroma may be caused by patient individual reasons (e.G.Individual poor wound healing, high activity level), by the surgical procedure itself or e.G.By an implant that influences wound healing (e.G.The implanted silicone.Implants).However, the reporter clarified that the patient did not have any relevant medical history (except for the use of tobacco and the chemotherapy) and no relevant concomitant medications have been administered that may have contributed to the formation of the seroma.A batch documentation analysis has been performed and revealed no issues during the production process.The investigator reported the causality of seroma as unknown regarding the fortiva membrane and related regarding the procedure.However, the date of the surgical procedure was reported as (b)(6) 2021 and the event onset as (b)(6) 2021.Timely relationship is therefore considered rather not plausible.Therefore, tutogen considers the event as not related.Seroma is already described in the ifu.
|